Hormone Replacement Therapy and Plasma Homocysteine Levels
- 1 October 1999
- journal article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 94 (4) , 485-491
- https://doi.org/10.1097/00006250-199910000-00001
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Hyperhomocysteinaemia and protein S deficiency in complicated pregnanciesBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemiaQJM: An International Journal of Medicine, 1996
- Hyperhomocysteinemia: a risk factor for placental abruption or infarctionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Biological Chemistry of Thiols in the Vasculature and in Vascular-related DiseaseNutrition Reviews, 1996
- Hyperhomocysteinemia and Low Pyridoxal PhosphateCirculation, 1995
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Homocyst(e)ine and arterial occlusive diseasesJournal of Internal Medicine, 1994
- Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?QJM: An International Journal of Medicine, 1993